Dermatologia – Paliativos Sem Fronteiras-Brasil

[kc_row use_container=”yes” force=”no” column_align=”middle” video_mute=”no” _id=”160442″][kc_column width=”12/12″ video_mute=”no” _id=”163868″][kc_column_text]

Classification of the cutaneous manifestations of COVID_19 a rapid prospective nationwide consensus study in Spain with 375 cases_Supplementary material Photographic atlas.pdf

Comment on Cutaneous manifestations in COVID‐19 a first perspective. Safety concerns of clinical images and skin biopsies-3229426.pdf

Comment on “Cutaneous manifestations in COVID‐19 a first perspective ” by Recalcati S-32314436.pdf

Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019_32170800.pdf

COVID-19 and Cutaneous manifestations-32229427.pdf

Covid-19 pandemic and the skin – What should dermatologists know?_10.1016/j.clindermatol.2020.03.012.pdf

Creating Dermatology Guidelines for Covid-19 The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease-32278795.pdf

Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy_32315073.pdf

Cutaneous manifestations in COVID-19 a first perspective_32215952.pdf

Cutaneous manifestations in COVID-19 Lessons learned from current evidence- 32339706.pdf

Cutaneous Manifestations in COVID-19: A New Contribution_32294264.pdf

Cutaneous manifestations in COVID‐19 the experiences of Barcelona and Rome-32330340.pdf

Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice_32320091.pdf

Dermatology staff participate in fight against Covid‐19 in China_32201983.pdf

Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus implications for the dermatology department-32141058.pdf

Immune Thrombocytopenic Purpura in a Patient with Covid-19-32294340.pdf

Manifestaciones cutáneas en contexto del brote actual de enfermedad por Coronavirus 2019.pdf

Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic-32171807.pdf

Skin cancer triage and management during COVID‐19 pandemic-32333832.pdf

Skin Damage Among Health Care Workers Managing Coronavirus disease-2019_32171808.pdf

Skin damage among healthcare workers managing coronavirus disease-2019 – PMID32171808.pdf

Skin Reactions to Non‐glove Personal Protective Equipment An Emerging Issue in the COVID‐19 Pandemic-32302444.pdf

Teledermatology a useful tool to fight COVID 19-32238000.pdf

The COVID‐19 outbreak and rheumatologic skin diseases-32237261.pdf

The impact of COVID‐19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy the Northern Italy experience-32343839.pdf

Urticarial eruption in COVID‐19 infection-.pdf

Varicella-like exanthem as a specific COVID-19-associated skin manifestation multicenter case series of 22 patients-32305439.pdf

Vascular skin symptoms in COVID‐19 a french observational study-32339344.pdf

[/kc_column_text][/kc_column][/kc_row]